Depth of metabolic response at interim PET and survival outcomes among patients with primary refractory and early relapsing diffuse large B-cell lymphoma (DLBCL).

Authors

null

Allison Marie Bock

Mayo Clinic, Rochester, MN

Allison Marie Bock , Raphael Mwangi , Fatemah Ataei , Matthew Thorpe , Matthew J. Maurer , Joshua Pritchett , Jacob Tyler Shreve , Jonas Paludo , Arushi Khurana , James Robert Cerhan , Thomas E. Witzig , Thomas Matthew Habermann , Yucai Wang , Jason R. Young , Grzegorz S. Nowakowski

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Track

Hematologic Malignancies

Sub Track

Non-Hodgkin Lymphoma

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 7543)

DOI

10.1200/JCO.2023.41.16_suppl.7543

Abstract #

7543

Poster Bd #

94

Abstract Disclosures